Generics Cos. Urge Fed. Circ. To Upend Depomed Patent Win
A group of generic-drug makers urged a Federal Circuit panel Tuesday to nix patents upheld, and found infringed, for Depomed Inc.'s opioid painkiller Nucynta, arguing that the patents cover follow-on developments...To view the full article, register now.
Already a subscriber? Click here to view full article